Opportunities and challenges for use of minipigs in nonclinical pharmaceutical development: Results of a follow-up IQ DruSafe surveyDavid O. Clarke, Thierry Flandre, Drew Olaharski et al.|Regulatory Toxicology and Pharmacology|2024Cited by 4
LP-18: Challenges and Opportunities in Use of the Minipig for Nonclinical Pharmaceutical Development: Results of the Second IQ DruSafe Minipig SurveyJoanna Harding, Béatrice Gauthier, Kaushik Datta et al.|Toxicology Letters|2023Cited by 0